Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000498070 | SCV000590371 | uncertain significance | not provided | 2017-06-12 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the DSP gene. The L1566V variant has not been published as pathogenic or been reported as benign to our knowledge. This variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This substitution occurs at a position that is conserved across species. However, the L1566V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Finally, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. |
Labcorp Genetics |
RCV000792630 | SCV000931936 | likely benign | Arrhythmogenic cardiomyopathy with wooly hair and keratoderma; Arrhythmogenic right ventricular dysplasia 8 | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001185498 | SCV001351723 | uncertain significance | Cardiomyopathy | 2024-03-25 | criteria provided, single submitter | clinical testing | This missense variant replaces leucine with valine at codon 1566 of the DSP protein. Computational prediction suggests that this variant may not impact protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 7/250376 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Institute of Human Genetics, |
RCV001262576 | SCV001440498 | uncertain significance | Arrhythmogenic right ventricular dysplasia 8 | 2019-01-01 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001185498 | SCV002043295 | uncertain significance | Cardiomyopathy | 2021-04-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002341176 | SCV002639993 | uncertain significance | Cardiovascular phenotype | 2025-02-05 | criteria provided, single submitter | clinical testing | The p.L1566V variant (also known as c.4696C>G), located in coding exon 23 of the DSP gene, results from a C to G substitution at nucleotide position 4696. The leucine at codon 1566 is replaced by valine, an amino acid with highly similar properties. This variant was has been detected in a peripartum cardiomyopathy cohort (Goli R et al. Circulation, 2021 May;143:1852-1862). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |
All of Us Research Program, |
RCV004003506 | SCV004818597 | uncertain significance | Arrhythmogenic cardiomyopathy with wooly hair and keratoderma | 2024-09-23 | criteria provided, single submitter | clinical testing | This missense variant replaces leucine with valine at codon 1566 of the DSP protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 7/250376 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Clinical Genetics Laboratory, |
RCV000498070 | SCV005197783 | uncertain significance | not provided | 2022-05-27 | criteria provided, single submitter | clinical testing |